Cost-Effectiveness of a Short Message Service Intervention to Prevent Type 2 Diabetes from Impaired Glucose Tolerance

Journal of Diabetes Research
Carlos K H WongCindy L K Lam

Abstract

Aims. To investigate the costs and cost-effectiveness of a short message service (SMS) intervention to prevent the onset of type 2 diabetes mellitus (T2DM) in subjects with impaired glucose tolerance (IGT). Methods. A Markov model was developed to simulate the cost and effectiveness outcomes of the SMS intervention and usual clinical practice from the health provider's perspective. The direct programme costs and the two-year SMS intervention costs were evaluated in subjects with IGT. All costs were expressed in 2011 US dollars. The incremental cost-effectiveness ratio was calculated as cost per T2DM onset prevented, cost per life year gained, and cost per quality adjusted life year (QALY) gained. Results. Within the two-year trial period, the net intervention cost of the SMS group was $42.03 per subject. The SMS intervention managed to reduce 5.05% onset of diabetes, resulting in saving $118.39 per subject over two years. In the lifetime model, the SMS intervention dominated the control by gaining an additional 0.071 QALY and saving $1020.35 per person. The SMS intervention remained dominant in all sensitivity analyses. Conclusions. The SMS intervention for IGT subjects had the superiority of lower monetary cost and a considera...Continue Reading

Associated Clinical Trials

Mar 16, 2012·WONG King Ho Carlos

References

Oct 1, 1993·Medical Decision Making : an International Journal of the Society for Medical Decision Making·F A Sonnenberg, J R Beck
Oct 23, 1996·JAMA : the Journal of the American Medical Association·J E SiegelM R Gold
Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Jul 29, 2003·Diabetes Care·Michael BrandleWilliam H Herman
Oct 23, 2004·Diabetic Medicine : a Journal of the British Diabetic Association·J J CaroJ A O'Brien
Mar 2, 2005·Annals of Internal Medicine·William H HermanUNKNOWN Diabetes Prevention Program Research Group
Dec 29, 2006·PharmacoEconomics·Rachael L Fleurence, Christopher S Hollenbeak
May 12, 2007·International Journal of Technology Assessment in Health Care·Peter LindgrenUNKNOWN DPS Study Group
Aug 19, 2007·Diabetes Care·Thomas J HoergerMichael M Engelgau
Aug 30, 2007·International Journal of Clinical Pharmacology and Therapeutics·B S W ChanK K C Lee
Oct 6, 2007·Health Promotion International·Kim Dalziel, Leonie Segal
Jan 22, 2008·Journal of the American College of Cardiology·Yamini S LevitzkyCaroline S Fox
Apr 23, 2008·BMJ : British Medical Journal·Clare L GilliesKamlesh Khunti
May 1, 2008·Journal of Diabetes Science and Technology·Santosh Krishna, Suzanne Austin Boren
Mar 5, 2010·The New England Journal of Medicine·Elizabeth SelvinFrederick L Brancati
Jul 1, 2010·Diabetes Care·Ranee ChatterjeeLawrence S Phillips
Sep 15, 2010·Archives of Internal Medicine·Margareta K ErikssonMats Eliasson
Mar 4, 2011·The New England Journal of Medicine·Sreenivasa Rao Kondapally SeshasaiUNKNOWN Emerging Risk Factors Collaboration
Nov 30, 2011·BMJ : British Medical Journal·Douglas NobleTrisha Greenhalgh
Jul 10, 2012·Journal of Occupational and Environmental Medicine·Carlos K H WongCindy L K Lam
Mar 8, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Mar 7, 2014·Applied Health Economics and Health Policy·P WatsonA Brennan
Mar 19, 2014·Diabetes Research and Clinical Practice·L GuariguataJ E Shaw

❮ Previous
Next ❯

Citations

Oct 13, 2018·BMC Research Notes·Carlos K H WongCindy L K Lam
Jan 29, 2020·Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates·Zeynep Kızılcık ÖzkanŞükriye Fidan
May 20, 2020·PloS One·Diego Chambergo-MichilotAlvaro Taype-Rondan
Mar 14, 2020·BMC Endocrine Disorders·Ruben WillemsUNKNOWN Feel4Diabetes research group
Mar 5, 2019·Diabetes, Obesity & Metabolism·Jose LealTalitha Feenstra
Jan 22, 2020·The British Journal of Clinical Psychology·Sam MalinsRichard Morriss
Jul 30, 2021·Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association·Jessica DawsonVincent W Lee

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01556880

Software Mentioned

TreeAge Pro
TreeAge

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.